Dose-response of cyclosporin A in attenuating traumatic axonal injury in rat |
| |
Authors: | Okonkwo David O Melon David E Pellicane Anthony J Mutlu Leman K Rubin David G Stone James R Helm Gregory A |
| |
Institution: | Departments of Neuroscience and Neurological Surgery, University of Virginia, PO Box 800212, Charlottesville, VA 22908, USA. doo5a@hscmail.mcc.virginia.edu |
| |
Abstract: | Cyclosporin A has emerged as a promising therapeutic agent in traumatic brain injury (TBI), although its precise neuroprotective mechanism is unclear. Cyclosporin A, given as a single-dose intrathecal bolus, has previously been shown to attenuate mitochondrial damage and reduce axonal injury in experimental TBI. We assessed the effect of a range of intravenous cyclosporin A doses upon axonal injury attenuation to determine the ideal dose. Rats were subjected to experimental TBI and given one of five intravenous doses of cyclosporin A. At 3 h post-injury, brains were processed for brain tissue cyclosporin A concentration. In a second set of animals, at 24 h postinjury, brains were processed for amyloid precursor protein immunoreactivity, a widely used marker of axonal injury. Intravenous administration produced therapeutic levels of cyclosporin A in brain parenchyma. Higher concentrations were achieved with equivalent doses given intrathecally; this is consistent with the reported poor blood-brain barrier permeability of cyclosporin A. Cyclosporin A 10 mg/kg i.v. produced the greatest degree of neuroprotection against diffuse axonal injury; cyclosporin A 50 mg/kg i.v. was toxic. Intravenous cyclosporin A administration achieves therapeutic levels in brain parenchyma and 10 mg/kg is the most effective dose in attenuating axonal damage after traumatic brain injury. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|